Ruilope, Luis M.

Finerenone Reduces Risk of Incident Heart Failure in Patients With Chronic Kidney Disease and Type 2 Diabetes: Analyses From the FIGARO-DKD Trial

Filippatos, G., Anker, S. D., Agarwal, R., Ruilope, L. M., Rossing, P., Bakris, G. L., Tasto, C., Joseph, A., Kolkhof, P., Lage, A., et al. (2022) · Circulation

Chronic Kidney Disease and DiabetesHeart Failure Treatment and Management

Cited by 299

Finerenone and cardiovascular outcomes in patients with chronic kidney disease and type 2 diabetes

Filippatos, G., Anker, S. D., Agarwal, R., Pitt, B., Ruilope, L. M., Rossing, P., Kolkhof, P., Schloemer, P., Tornus, I., Joseph, A., et al. (2021) · Circulation

Chronic Kidney Disease and DiabetesHormonal Regulation and Hypertension

Cited by 294

Relationship between clinic and ambulatory blood pressure and mortality: an observational cohort study in 59 124 patients

Staplin, N., de la Sierra, A., Ruilope, L. M., Emberson, J. R., Vinyoles, E., Gorostidi, M., Ruiz-Hurtado, G., Segura, J., Baigent, C., & Williams, B. (2023) · The Lancet

Blood Pressure and Hypertension StudiesCardiovascular Health and Disease Prevention

Cited by 290

A double-blind, randomized study comparing the antihypertensive effect of eplerenone and spironolactone in patients with hypertension and evidence of primary aldosteronism

Parthasarathy, H. K., Ménard, J., White, W. B., Young, W. F., Williams, G. H., Williams, B., Ruilope, L. M., McInnes, G. T., Connell, J. M., & MacDonald, T. M. (2011) · Journal of Hypertension

Hormonal Regulation and HypertensionBlood Pressure and Hypertension Studies

Cited by 281

Hyperkalemia risk with finerenone: results from the FIDELIO-DKD Trial

Agarwal, R., Joseph, A., Anker, S. D., Filippatos, G., Rossing, P., Ruilope, L. M., Pitt, B., Kolkhof, P., Scott, C., Lawatscheck, R., et al. (2022) · Journal of the American Society of Nephrology

Potassium and Related DisordersChronic Kidney Disease and Diabetes

Cited by 262

Exercise benefits in cardiovascular diseases: From mechanisms to clinical implementation

Valenzuela, P. L., Ruilope, L. M., Santos-Lozano, A., Wilhelm, M., Kränkel, N., Fiuza-Luces, C., & Lucia, A. (2023) · European Heart Journal

Cardiovascular and exercise physiologyPhysical Activity and Health

Cited by 237

Clinical outcome endpoints in heart failure trials: a European Society of Cardiology Heart Failure Association consensus document

Zannad, F., Garcia, A. A., Anker, S. D., Armstrong, P. W., Calvo, G., Cleland, J. G. F., Cohn, J. N., Dickstein, K., Domanski, M. J., Ekman, I., et al. (2013) · European Journal of Heart Failure

Heart Failure Treatment and ManagementStatistical Methods in Clinical Trials

Cited by 231

Design and Baseline Characteristics of the Finerenone in Reducing Kidney Failure and Disease Progression in Diabetic Kidney Disease Trial

Bakris, G. L., Agarwal, R., Anker, S. D., Pitt, B., Ruilope, L. M., Nowack, C., Kolkhof, P., Ferreira, A. C., Schloemer, P., Filippatos, G., et al. (2019) · American Journal of Nephrology

Chronic Kidney Disease and DiabetesAcute Kidney Injury Research

Cited by 184

Finerenone reduces new-onset atrial fibrillation in patients with chronic kidney disease and type 2 diabetes

Filippatos, G., Bakris, G. L., Pitt, B., Agarwal, R., Rossing, P., Ruilope, L. M., Butler, J., Lam, C. S. P., Kolkhof, P., Roberts, L., et al. (2021) · Journal of the American College of Cardiology

Atrial Fibrillation Management and OutcomesChronic Kidney Disease and Diabetes

Cited by 153

Clinical differences between resistant hypertensives and patients treated and controlled with three or less drugs

de la Sierra, A., Banegas, J. R., Oliveras, A., Gorostidi, M., Segura, J., de la Cruz, J. J., Armario, P., & Ruilope, L. M. (2012) · Journal of Hypertension

Blood Pressure and Hypertension StudiesHormonal Regulation and Hypertension

Cited by 147

Ethnic Differences in the Degree of Morning Blood Pressure Surge and in Its Determinants Between Japanese and European Hypertensive Subjects: Data From the ARTEMIS Study

Hoshide, S., Kario, K., de la Sierra, A., Bilo, G., Schillaci, G., Banegas, J. R., Gorostidi, M., Segura, J., Lombardi, C., Omboni, S., et al. (2015) · Hypertension

Blood Pressure and Hypertension StudiesCardiovascular Health and Disease Prevention

Cited by 117

Long-term renal survival in malignant hypertension

Gonzalez, R., Morales, E., Segura, J., Ruilope, L. M., & Praga, M. (2010) · Nephrology Dialysis Transplantation

Blood Pressure and Hypertension StudiesChronic Kidney Disease and Diabetes

Cited by 116

Impact of Finerenone-Induced Albuminuria Reduction on Chronic Kidney Disease Outcomes in Type 2 Diabetes: A Mediation Analysis

Agarwal, R., Tu, W., Farjat, A. E., Farag, Y. M. K., Toto, R., Kaul, S., Lawatscheck, R., Rohwedder, K., Ruilope, L. M., Rossing, P., et al. (2023) · Annals of Internal Medicine

Chronic Kidney Disease and DiabetesHormonal Regulation and Hypertension

Cited by 109

Investigating new treatment opportunities for patients with chronic kidney disease in type 2 diabetes: the role of finerenone

Agarwal, R., Anker, S. D., Bakris, G., Filippatos, G., Pitt, B., Rossing, P., Ruilope, L., Gebel, M., Kolkhof, P., Nowack, C., et al. (2022) · Nephrology Dialysis Transplantation

Chronic Kidney Disease and DiabetesHormonal Regulation and Hypertension

Cited by 103

Low-dose aspirin does not interfere with the blood pressure-lowering effects of antihypertensive therapy.

Zanchetti, A., Hansson, L., Leonetti, G., Rahn, K.-H., Ruilope, L., Warnold, I., & Wedel, H. (2002) · Journal of Hypertension

Blood Pressure and Hypertension StudiesAntiplatelet Therapy and Cardiovascular Diseases

Cited by 89

Renal denervation in patients with versus without chronic kidney disease: results from the Global SYMPLICITY Registry with follow-up data of 3 years

Ott, C., Mahfoud, F., Mancia, G., Narkiewicz, K., Ruilope, L. M., Fahy, M., Schlaich, M. P., Böhm, M., & Schmieder, R. E. (2022) · Nephrology Dialysis Transplantation

Blood Pressure and Hypertension StudiesRenal and Vascular Pathologies

Cited by 62

Physical exercise and epicardial adipose tissue: A systematic review and meta-analysis of randomized controlled trials

Saco‐Ledo, G., Valenzuela, P. L., Castillo‐García, A., Arenas, J., León‐Sanz, M., Ruilope, L. M., & Lucia, A. (2021) · Obesity Reviews

Cardiovascular Disease and AdiposityPhysical Activity and Health

Cited by 47

Effects of Captopril on Sympathetic Activity, Lipid and Carbohydrate Metabolism in a Model of Obesity-Induced Hypertension in Dogs

Robles, R. G., Villa, E., Santirso, R., Martinez, J., Ruilope, L. M., Carmen, C., & Sancho, J. M. (1993) · American Journal of Hypertension

Blood Pressure and Hypertension StudiesRenin-Angiotensin System Studies

Cited by 42

Effects of Chronic Combined Treatment With Captopril and Pravastatin on the Progression of Insulin Resistance and Cardiovascular Alterations in an Experimental Model of Obesity in Dogs

Villa, E., Rabano, A., Albarran, O. G., Ruilope, L. M., & Garcia-Robles, R. (1998) · American Journal of Hypertension

Diabetes, Cardiovascular Risks, and LipoproteinsCardiovascular Function and Risk Factors

Cited by 11